This provider's $5.0M in total Medicare payments ranks in the 81th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 317% from 2022 to 2023.
61% of their billing comes from a single procedure code (87637 — Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus).
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 317% in 2023
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2022 | $150.14 | $34.21 | 4.39x | $115.93 | $969.8K | 28.3K | 7 |
| 2023 | $297.10 | $106.72 | 2.78x | $190.38 | $4.0M | 37.9K | 8 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 87637 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 22.0K | $3.1M | $139.78 | 2.50x |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | 14.1K | $1.3M | $93.94 | 3.30x |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 4.5K | $226.3K | $50.36 | 5.23x |
| 87400 | Detection test by immunoassay technique for influenza virus | 14.1K | $196.1K | $13.87 | 7.21x |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4.5K | $104.3K | $23.03 | 3.26x |
| 82784 | Gammaglobulin (immune system protein) measurement | 6.6K | $60.4K | $9.13 | 6.57x |
| 86409 | Measurement of neutralizing antibody to severe acute respiratory syndrome coronavirus 2 (covid-19) | 303 | $23.7K | $78.15 | 3.97x |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 37 | $1.9K | $50.28 | 5.17x |
This provider submits charges 3.09 times higher than what Medicare actually pays.
A markup ratio of 3.09x means for every $100 Medicare pays, this provider initially charges $309. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in CA for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Genomic Health, Inc. | Redwood City, CA | $887.6M | ✓ Clear |
| Unilab Corporation | West Hills, CA | $868.8M | ⚠️ Flagged |
| Caredx Inc. | Brisbane, CA | $751.0M | ✓ Clear |
| Laboratory Corporation Of America | San Diego, CA | $592.4M | ⚠️ Flagged |
| Millennium Health, Llc | San Diego, CA | $587.9M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data